These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6490569)
1. Pharmacokinetics of the oral triazole antimycotic vibunazole in animals. Ritter W; Plempel M J Antimicrob Chemother; 1984 Sep; 14(3):243-52. PubMed ID: 6490569 [TBL] [Abstract][Full Text] [Related]
2. Interspecies comparison of pharmacokinetics of the novel triazole antifungal agent SYN-2869 and its derivatives. Khan JK; Montaseri H; Poglod M; Bu HZ; Zuo Z; Salama SM; Daneshtalab M; Micetich RG Antimicrob Agents Chemother; 2000 Apr; 44(4):910-5. PubMed ID: 10722490 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys. Nomeir AA; Kumari P; Hilbert MJ; Gupta S; Loebenberg D; Cacciapuoti A; Hare R; Miller GH; Lin CC; Cayen MN Antimicrob Agents Chemother; 2000 Mar; 44(3):727-31. PubMed ID: 10681346 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of vibunazole (BAY n 7133) administered orally to healthy subjects. van Gulpen C; Kelder O; Mattie H; van der Meer JW; van't Wout J J Antimicrob Chemother; 1985 Jul; 16(1):75-9. PubMed ID: 4044466 [TBL] [Abstract][Full Text] [Related]
5. Half-lives in plasma and bioavailability of ethinylestradiol in laboratory animals. Düsterberg B; Kühne G; Täuber U Arzneimittelforschung; 1986 Aug; 36(8):1187-90. PubMed ID: 3778555 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species. Monbaliu J; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W Arzneimittelforschung; 2003; 53(7):486-95. PubMed ID: 12918214 [TBL] [Abstract][Full Text] [Related]
7. New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice. Lefler E; Stevens DA J Antimicrob Chemother; 1985 Jan; 15(1):69-75. PubMed ID: 3972759 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cyanamide in dog and rat. Obach R; Colom H; Arso J; Peraire C; Pruñonosa J J Pharm Pharmacol; 1989 Sep; 41(9):624-7. PubMed ID: 2573707 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of 1954U89, 1,3-diamino-7-(1-ethylpropyl)-8-methyl-7H-pyrrolo-(3,2-f)quinazoline, in dogs and rats after intravenous and oral administration. Studenberg SD; Woolley JL; Deangelis DV; Wargin WA Biopharm Drug Dispos; 1997 Jul; 18(5):433-42. PubMed ID: 9210981 [TBL] [Abstract][Full Text] [Related]
11. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs. Kendall J; Papich MG Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic evaluation of fluconazole in healthy volunteers]. Shiba K; Saito A; Miyahara T Jpn J Antibiot; 1989 Jan; 42(1):17-30. PubMed ID: 2540363 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human. Timchalk C; Nolan RJ Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Humphrey MJ; Jevons S; Tarbit MH Antimicrob Agents Chemother; 1985 Nov; 28(5):648-53. PubMed ID: 3004323 [TBL] [Abstract][Full Text] [Related]
15. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound. Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of TH-302: a hypoxically activated prodrug of bromo-isophosphoramide mustard in mice, rats, dogs and monkeys. Jung D; Lin L; Jiao H; Cai X; Duan JX; Matteucci M Cancer Chemother Pharmacol; 2012 Mar; 69(3):643-54. PubMed ID: 21964906 [TBL] [Abstract][Full Text] [Related]
18. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys. Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673 [TBL] [Abstract][Full Text] [Related]
19. Metabolic disposition and pharmacokinetics of pelrinone, a new cardiotonic drug, in laboratory animals and man. Scatina JA; Hicks DR; Kraml M; Cayen MN Eur J Drug Metab Pharmacokinet; 1990; 15(1):37-48. PubMed ID: 2384116 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of L-671,329 in rhesus monkeys and DBA/2 mice. Sundelof JG; Hajdu R; Cleare WJ; Onishi J; Kropp H Antimicrob Agents Chemother; 1992 Mar; 36(3):607-10. PubMed ID: 1622170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]